M. Fox
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
Papers in
-
- Multiple Myeloma Research and Treatments 5
- Chronic Myeloid Leukemia Treatments 2
- Acute Myeloid Leukemia Research 2
-
- Protein Degradation and Inhibitors 2
- Cancer therapeutics and mechanisms 1
- Co-authors
- Guido Tricot (6 shared papers)Elias Anaissie (3 shared papers)Athanasios Fassas (3 shared papers)Klaus Hollmig (4 shared papers)Bart Barlogie (4 shared papers)Erik Rasmussen (3 shared papers)Maurizio Zangari (5 shared papers)Frits van Rhee (5 shared papers)
- Journals
- Blood (3 papers)Journal of Clinical Oncology (2 papers)Human Gene Therapy (1 paper)The International Journal of Biological Markers (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
M. Fox
9 papers receiving 546 citations
M. Fox's Hit Papers
Peers
Comparison fields: 5 of 55
- Hematology 487
- Oncology 297
- Internal Medicine 26
- Genetics 63
- Molecular Biology 380
Countries citing papers authored by M. Fox
This map shows the geographic impact of M. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Fox more than expected).
Fields of papers citing papers by M. Fox
This network shows the impact of papers produced by M. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Fox. The network helps show where M. Fox may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Fox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma Hit paper breakdown → | 2006 | 532 |
| 2 | 1996 | 11 | |
| 3 | 1993 | 8 | |
| 4 | 2014 | 3 | |
| 5 | 2004 | 3 | |
| 6 | 2005 | 2 | |
| 7 | 2005 | 2 | |
| 8 | 2005 | 1 | |
| 9 | 2004 | 1 |
About M. Fox
M. Fox is a scholar working on Hematology, Molecular Biology, Genetics, Pathology and Forensic Medicine and Oncology, having authored 9 papers that have together received 563 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cancer Genomics and Diagnostics (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Hematology (487 citations), Oncology (297 citations), Internal Medicine (26 citations), Genetics (63 citations) and Molecular Biology (380 citations). M. Fox has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Guido Tricot, Elias Anaissie, Athanasios Fassas, Klaus Hollmig, Bart Barlogie, Erik Rasmussen, Maurizio Zangari, Frits van Rhee, Giampaolo Talamo and Mauricio Pineda‐Roman. Their work appears in journals such as Blood, Journal of Clinical Oncology, Human Gene Therapy, The International Journal of Biological Markers and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.